Search
Vaxart to Present Research on Second-Generation Norovirus Oral Pill Vaccine Candidate at IDWeek 2025
October 20, 2025 - … 19-22, 2025 , at the Georgia World Congress Center in Atlanta . IDWeek Oral Abstract Presentation: Presentation … 19-22, 2025 , at the Georgia World Congress Center in Atlanta . IDWeek Oral Abstract Presentation: Presentation … 19-22, 2025 , at the Georgia World Congress Center in Atlanta . IDWeek Oral Abstract Presentation: Presentation …
Vaxart to Host Webcast with Key Opinion Leaders to Discuss the Health Impact and Disease Burden for Norovirus
March 17, 2023 - … the Centers for Disease Control and Prevention ( CDC ) in Atlanta, GA. Dr. Vinjé received his Ph.D. degree at the … the Centers for Disease Control and Prevention ( CDC ) in Atlanta, GA. Dr. Vinjé received his Ph.D. degree at the … the Centers for Disease Control and Prevention ( CDC ) in Atlanta, GA. Dr. Vinjé received his Ph.D. degree at the …
Vaxart Announces Creation of Manufacturing and Quality Advisory Board
September 21, 2021 - … an Adjunct Faculty member at Georgia State University in Atlanta , Georgia. Vijay Jethwa , Ph.D. Senior … an Adjunct Faculty member at Georgia State University in Atlanta , Georgia. Vijay Jethwa , Ph.D. Senior … an Adjunct Faculty member at Georgia State University in Atlanta , Georgia. Vijay Jethwa , Ph.D. Senior …
Vaxart Announces Exclusive Worldwide License Agreement with Altesa Biosciences for its Vapendavir Antiviral Asset
July 7, 2021 - … a clinical-stage pharmaceutical company headquartered in Atlanta, Georgia . Altesa is developing therapeutics … a clinical-stage pharmaceutical company headquartered in Atlanta, Georgia . Altesa is developing therapeutics … a clinical-stage pharmaceutical company headquartered in Atlanta, Georgia . Altesa is developing therapeutics …
Vaxart Hosting Key Opinion Leader Panel Call for Investors
November 16, 2020 - … the Centers for Disease Control and Prevention ( CDC ) in Atlanta, GA. Dr. Vinjé received his Ph.D. at the University … the Centers for Disease Control and Prevention ( CDC ) in Atlanta, GA. Dr. Vinjé received his Ph.D. at the University … the Centers for Disease Control and Prevention ( CDC ) in Atlanta, GA. Dr. Vinjé received his Ph.D. at the University …
Vaxart to Present at ASM Microbe 2018
May 31, 2018 - … of Microbiology 2018, taking place from June 7-11, 2018 in Atlanta, Georgia . Details of the presentation are as … of Microbiology 2018, taking place from June 7-11, 2018 in Atlanta, Georgia . Details of the presentation are as … of Microbiology 2018, taking place from June 7-11, 2018 in Atlanta, Georgia . Details of the presentation are as …
Vaxart, Inc. Closes Merger with Aviragen Therapeutics, Inc.
February 14, 2018 - … Under New Symbol NASDAQ: VXRT SOUTH SAN FRANCISCO, CA and ATLANTA, Feb. 13, 2018 — Vaxart, Inc. (NASDAQ: VXRT) today … Under New Symbol NASDAQ: VXRT SOUTH SAN FRANCISCO, CA and ATLANTA, Feb. 13, 2018 — Vaxart, Inc. (NASDAQ: VXRT) today … Under New Symbol NASDAQ: VXRT SOUTH SAN FRANCISCO, CA and ATLANTA, Feb. 13, 2018 — Vaxart, Inc. (NASDAQ: VXRT) today …
Aviragen Adjourns Special Meeting of Stockholders to Allow Stockholders to Consider Improved Merger Deal Terms
February 9, 2018 - … Company Currently has Sufficient Votes to Approve Merger ATLANTA , Feb. 09, 2018 (GLOBE NEWSWIRE) -- Aviragen … Company Currently has Sufficient Votes to Approve Merger ATLANTA , Feb. 09, 2018 (GLOBE NEWSWIRE) -- Aviragen … Company Currently has Sufficient Votes to Approve Merger ATLANTA , Feb. 09, 2018 (GLOBE NEWSWIRE) -- Aviragen …
Aviragen and Vaxart Amend Terms of Merger Agreement to Increase the Value for Aviragen Stockholders
February 7, 2018 - … Value for Aviragen Stockholders February 7, 2018 Aviragen ATLANTA and SOUTH SAN FRANCISCO, Calif. , Feb. 07, 2018 … Value for Aviragen Stockholders February 7, 2018 Aviragen ATLANTA and SOUTH SAN FRANCISCO, Calif. , Feb. 07, 2018 … ATLANTA and SOUTH SAN FRANCISCO, Calif. , Feb. 07, 2018 …